Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1

Background: Clinical trials showed that only a subset of patients benefits from immunotherapy, suggesting the need to identify new predictive biomarker of resistance. Indoleamine-2,3-dioxygenase (IDO) has been proposed as a mechanism of resistance to anti-PD-1 treatment, and serum kynurenine/tryptop...

Descripción completa

Detalles Bibliográficos
Autores principales: Botticelli, Andrea, Mezi, Silvia, Pomati, Giulia, Cerbelli, Bruna, Cerbelli, Edoardo, Roberto, Michela, Giusti, Raffaele, Cortellini, Alessio, Lionetto, Luana, Scagnoli, Simone, Zizzari, Ilaria Grazia, Nuti, Marianna, Simmaco, Maurizio, Marchetti, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358280/
https://www.ncbi.nlm.nih.gov/pubmed/32733441
http://dx.doi.org/10.3389/fimmu.2020.01243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358280/
https://www.ncbi.nlm.nih.gov/pubmed/32733441
http://dx.doi.org/10.3389/fimmu.2020.01243

Ejemplares similares